![smith drug company google reviews smith drug company google reviews](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs13756-020-00714-9/MediaObjects/13756_2020_714_Fig1_HTML.png)
We welcome the opportunity to provide valuable solutions, along with our industry leading customer experience, to all of these healthcare providers.” Together, we will continue to offer the differentiated support independent community pharmacies need to thrive in an evolving healthcare marketplace. Smith in serving community pharmacies is strongly aligned with and complements the services AmerisourceBergen provides through Good Neighbor Pharmacy and Elevate Provider Network. Mauch, Group President, Pharmaceutical Distribution and Strategic Global Sourcing at AmerisourceBergen. Smith has always shared our passion for supporting its customers – across community pharmacy, health systems, long-term care and specialty distribution,” said Robert P. Importantly, we are united in our responsibility to create healthier futures.” We remain committed to building our business to meet the evolving needs of our customers, driving long-term value for the healthcare system and delivering compelling returns for our shareholders. “This acquisition also builds upon our foundation and meaningfully expands our support for independent community pharmacies. Collis, Chairman, President and Chief Executive Officer of AmerisourceBergen.
![smith drug company google reviews smith drug company google reviews](https://arc-anglerfish-washpost-prod-washpost.s3.amazonaws.com/public/YCNUD5VIDYI6TBW527YOMA4R5E.jpg)
pharmaceutical distribution,” said Steven H. Smith – a best-in-class private distributor with facilities across the country and a diversified customer base – strengthens our core business and expands and enhances our strategic scale in U.S. The transaction is subject to regulatory review and other closing conditions and is expected to close in early calendar 2018. AmerisourceBergen is reaffirming the rest of its previously announced fiscal 2018 financial guidance. Based on the estimated contribution of this acquisition, the Company now expects revenue growth to be in the range of 8 percent to 11 percent, adjusted operating income growth to be in the range of 4 percent to 7 percent and Pharmaceutical Distribution Services segment operating income growth in the range of 4 percent to 7 percent. This acquisition was not contemplated in the previous guidance the Company provided for fiscal year 2018.
Smith drug company google reviews full#
The acquisition is expected to be slightly accretive to adjusted diluted earnings per share (EPS) in fiscal year 2018, and to achieve full run-rate synergies and be approximately $0.15 accretive to the Company’s adjusted EPS in fiscal year 20201. AmerisourceBergen plans to fund the acquisition through the issuance of new long-term debt. Smith, the largest independent wholesaler in the U.S., for $815 million in cash. Smith today announced that the companies have signed a definitive agreement under which AmerisourceBergen will purchase H. AmerisourceBergen Corporation (NYSE:ABC) and H.